JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response
- 6 October 2014
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (42) , 15190-15195
Abstract
Significance: Cancers arise through a succession of enabling genetic lesions, but the consequences of many driver mutations remain unclear, especially in the earliest stages of tumor formation. The myeloproliferative neoplasms (MPNs) encompass a group of chronic hematologic disorders that can collectively provide a window into these early stages of leukemia evolution. This study reveals a role for the JAK2V617F mutation, the most frequent genetic abnormality in MPN patients, in impairing replication fork progression during cell division of MPN patient-derived tumor cells. Moreover, analysis of different MPN disease subtypes reveals unexpected differences in DNA repair activity in response to JAK2V617F-induced perturbations in replication dynamics. These findings have potential implications for tumor clonal evolution and individualized cancer therapy.Keywords
This publication has 39 references indexed in Scilit:
- Evolution of the cancer genomeNature Reviews Genetics, 2012
- A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stabilityNature Structural & Molecular Biology, 2010
- Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 SignalingCancer Cell, 2010
- STAT1 promotes megakaryopoiesis downstream of GATA-1 in miceJournal of Clinical Investigation, 2007
- Replication Fork Velocities at Adjacent Replication Origins Are Coordinately Modified during DNA Replication in Human CellsMolecular Biology of the Cell, 2007
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Double‐strand breaks arising by replication through a nick are repaired by cohesin‐dependent sister‐chromatid exchangeEMBO Reports, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005